Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Chang

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Lupus|January 13, 2010
Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosusH C Chan, L Y Ke, L L Chang, et al.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 15, 2024
End-of-life practices in Hong Kong intensive care units: results from the Ethicus-2 studyG M Joynt, S K H Ling, L L Chang, et al.
Journal of Cellular Biochemistry|March 18, 2000
Direct effects of prolactin on corticosterone release by zona fasciculata-reticularis cells from male ratsL L Chang, M J Lo, S F Kan, et al.
ESMO Open|July 7, 2026
Efficacy and safety of durvalumab plus gemcitabine-cisplatin in combined hepatocellular-cholangiocarcinoma versus cholangiocarcinomaC-C Hsu, K-Y Yeh, C-F Chang, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
The discovery of sulfonylated dipeptides as potent VLA-4 antagonistsW K Hagmann, P L Durette, T Lanza, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Medicinal Chemistry|September 15, 1995
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Journal of Medicinal Chemistry|December 23, 1994
Triazolinone biphenylsulfonamides as angiotensin II receptor antagonists with high affinity for both the AT1 and AT2 subtypesL L Chang, W T Ashton, K L Flanagan, et al.
Lupus|January 13, 2010
Suppressor of cytokine signaling 1 gene expression and polymorphisms in systemic lupus erythematosusH C Chan, L Y Ke, L L Chang, et al.
Journal of Medicinal Chemistry|August 19, 1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinityW T Ashton, L L Chang, K L Flanagan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 15, 2024
End-of-life practices in Hong Kong intensive care units: results from the Ethicus-2 studyG M Joynt, S K H Ling, L L Chang, et al.
Journal of Cellular Biochemistry|March 18, 2000
Direct effects of prolactin on corticosterone release by zona fasciculata-reticularis cells from male ratsL L Chang, M J Lo, S F Kan, et al.
ESMO Open|July 7, 2026
Efficacy and safety of durvalumab plus gemcitabine-cisplatin in combined hepatocellular-cholangiocarcinoma versus cholangiocarcinomaC-C Hsu, K-Y Yeh, C-F Chang, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
The discovery of sulfonylated dipeptides as potent VLA-4 antagonistsW K Hagmann, P L Durette, T Lanza, et al.
Pageof 7